Efficacy of sacituzumab govitecan based regimen in triple-negative breast cancer: A systematic review.

被引：0
|
作者：
Khalid, Farhan
Kashyap, Richi
Singh, Vinit
Tayyeb, Muhammad
Jaan, Ali
Mohan, Gaurav
Meghal, Trishala
机构：
[1] Monmouth Med Ctr, Dept Internal Med, Long Branch, NJ USA
[2] North Alabama Med Ctr, Dept Internal Med, Florence, AL USA
[3] Rochester Gen Hosp, Dept Internal Med, Rochester, NY USA
[4] Monmouth Med Ctr, Dept Med, Sect Hematol, Long Branch, NJ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13068
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Population Pharmacokinetics of Sacituzumab Govitecan in Patients with Metastatic Triple-Negative Breast Cancer and Other Solid Tumors
    Abhishek G. Sathe
    Indrajeet Singh
    Pratap Singh
    Paul M. Diderichsen
    Xiaohui Wang
    Peter Chang
    Atiya Taqui
    See Phan
    Sandhya Girish
    Ahmed A. Othman
    Clinical Pharmacokinetics, 2024, 63 : 669 - 681
  • [32] Revolutionizing triple-negative metastatic breast cancer treatment: sacituzumab Govitecan's role in advancing chemotherapy
    Qureshi, Zaheer
    Jamil, Abdur
    Altaf, Faryal
    Siddique, Rimsha
    Fatima, Eeshal
    Dost, Sara
    Zelkowitz, Richard Scott
    Shah, Shivendra
    ANNALS OF MEDICINE AND SURGERY, 2024, 86 (09): : 5314 - 5319
  • [33] Therapy in advanced triple-negative Breast Cancer in Transition Sacituzumab Govitecan - highly effective and easy to handle
    Pohlmann, Birgit-Kristin
    BREAST CARE, 2022, 17 (04) : 438 - 439
  • [34] Considerable Improvement in Overall Survival through Sacituzumab-Govitecan in metastatic triple-negative Breast Cancer
    Pervan, Mascha
    Krawczyk, Natalia
    Hanker, Lars
    Bundgen, Nana
    Rody, Achim
    Banys-Paluchowski, M.
    ONKOLOGE, 2021, 27 (11): : 1131 - 1136
  • [35] New drug approval: Sacituzumab govitecan in third line in advanced or metastatic triple-negative breast cancer
    Kabirian, Rayan
    Da Silva, Angelique
    BULLETIN DU CANCER, 2022, 109 (03) : 249 - 250
  • [36] Cost-effectiveness of sacituzumab govitecan versus chemotherapy in advanced or metastatic triple-negative breast cancer
    Lang, Yitian
    Chai, Qingqing
    Tao, Wenqi
    Liao, Yahui
    Liu, Xiaoyan
    Wu, Bin
    BREAST, 2023, 68 : 173 - 180
  • [37] Analysis of patients without and with an initial triple-negative breast cancer diagnosis in the phase 3 randomized ASCENT study of sacituzumab govitecan in metastatic triple-negative breast cancer
    O'Shaughnessy, Joyce
    Brufsky, Adam
    Rugo, Hope S.
    Tolaney, Sara M.
    Punie, Kevin
    Sardesai, Sagar
    Hamilton, Erika
    Loirat, Delphine
    Traina, Tiffany
    Leon-Ferre, Roberto
    Hurvitz, Sara A.
    Kalinsky, Kevin
    Bardia, Aditya
    Henry, Stephanie
    Mayer, Ingrid
    Zhu, Yanni
    Phan, See
    Cortes, Javier
    BREAST CANCER RESEARCH AND TREATMENT, 2022, 195 (02) : 127 - 139
  • [38] Analysis of patients without and with an initial triple-negative breast cancer diagnosis in the phase 3 randomized ASCENT study of sacituzumab govitecan in metastatic triple-negative breast cancer
    Joyce O’Shaughnessy
    Adam Brufsky
    Hope S. Rugo
    Sara M. Tolaney
    Kevin Punie
    Sagar Sardesai
    Erika Hamilton
    Delphine Loirat
    Tiffany Traina
    Roberto Leon-Ferre
    Sara A. Hurvitz
    Kevin Kalinsky
    Aditya Bardia
    Stephanie Henry
    Ingrid Mayer
    Yanni Zhu
    See Phan
    Javier Cortés
    Breast Cancer Research and Treatment, 2022, 195 : 127 - 139
  • [39] Sacituzumab Govitecan as a Second-Line Treatment in Relapsed/Refractory Metastatic Triple-Negative Breast Cancer Patients: A Systematic Review and Meta-analysis
    Kathpalia, Meghavi
    Sharma, Anurag
    Kaur, Navkiran
    ANNALS OF PHARMACOTHERAPY, 2024, 58 (01) : 44 - 53
  • [40] Trilaciclib combined with sacituzumab govitecan (SG) in metastatic triple-negative breast cancer (mTNBC): Updated phase 2 safety and efficacy results
    Seneviratne, Lasika C.
    Harnden, Kathleen Kiernan
    Blau, Sibel
    Danso, Michael A.
    Berz, David
    Guaqueta, Delia Constanza
    Schwerkoske, John F.
    O'Shaughnessy, Joyce
    Patt, Debra A.
    Bardia, Aditya
    McCann, Kelly Elizabeth
    Beelen, Andrew Paul
    Zhang, Jingshan
    Yi, John S.
    Hurvitz, Sara A.
    Mardones, Mabel Alejandra
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345